Literature DB >> 6294699

C-terminal octapeptide of cholecystokinin decreases food intake in obese men.

X Pi-Sunyer, H R Kissileff, J Thornton, G P Smith.   

Abstract

Six of eight obese men ate significantly less food during an intravenous infusion of the C-terminal octapeptide of cholecystokinin (CCK-8, 4 ng . kg-1 . min-1) than during a saline infusion in a double blind experimental paradigm. Subjects stopped eating sooner during CCK-8. CCK-8 did not change the rate of eating. No overt side effects were reported or observed. This is the first report of the satiety effect of CCK-8 in obese humans and it suggests that the therapeutic potential of CCK-8 for the treatment of obesity deserves investigation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294699     DOI: 10.1016/0031-9384(82)90230-x

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  25 in total

1.  Obesity and gastrointestinal sensory-motor function.

Authors:  G Anton Decker; Michael D Crowell
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

Review 2.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 4.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 5.  The gut sensor as regulator of body weight.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  Endocrine       Date:  2014-12-30       Impact factor: 3.633

6.  Role of Enteroendocrine Hormones in Appetite and Glycemia.

Authors:  Maria Laura Ricardo-Silgado; Alison McRae; Andres Acosta
Journal:  Obes Med       Date:  2021-03-12

7.  CCK increases the transport of insulin into the brain.

Authors:  Aaron A May; Min Liu; Stephen C Woods; Denovan P Begg
Journal:  Physiol Behav       Date:  2016-08-26

8.  Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding.

Authors:  Mousumi Bose; Sriram Machineni; Blanca Oliván; Julio Teixeira; James J McGinty; Baani Bawa; Ninan Koshy; Antonia Colarusso; Blandine Laferrère
Journal:  Obesity (Silver Spring)       Date:  2010-01-07       Impact factor: 5.002

9.  Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.

Authors:  R J Lieverse; J B Jansen; A A Masclee; L C Rovati; C B Lamers
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

10.  Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.

Authors:  S J Cooper; C T Dourish; D J Barber
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.